,i #aaith ,,congress #b;d ,session ,h4 ,r4 #iaib ,,in ,,the ,,house ,,of ,,representatives ,june #h1 #bjbf,ms4 ,johnson of ,texas 7for herself and ,mr4 ,lawler7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committees on ,education and ,workforce1 and ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend the ,employee ,retirement ,income ,security ,act of #aigd1 title ,,xxvii of the ,public ,health ,service ,act1 and the ,internal ,revenue ,code of #aihf to require health insurance coverage of drugs indicated for the treatment of autoimmune diseases and certain blood disorders4 #a4 ,short title ,this ,act may be cited as the ,prior ,authorization ,reform for ,autoimmune and ,blood ,disorders ,act4 #b4 ,requiring coverage of drugs indicated for the treatment of autoimmune diseases and certain blood disorders 7a7 ,,erisa amendments 7#a7 ,in general ,subpart ,b of part #g of subtitle ,b of title ,i of the ,employee ,retirement ,income ,security ,act of #aigd 7#bi ,u4,s4,c4 #aahe et seq47 is amended by adding at the end the following new section3 #gbg4 ,requirements with respect to coverage of drugs for autoimmune diseases and certain blood disorders 7a7 ,in general ,a group health plan1 and a health insurance issuer offering group health insurance coverage-- 7#a7 shall provide coverage for any drug that is an autoimmune or blood disorder drug1 without regard to whether such drug is dispensed by a pharmacy or furnished incident to another item or service for which benefits are available under such plan or coverage2 and 7#b7 may not require1 with respect to an individual enrolled under such plan or coverage1 that prior authorization for such a drug be obtained more than once during any #ab-month period unless such drug is-- 7,a7 typically used for a period of #ab months or less2 7,b7 an opioid1 a benzodiazepine1 a barbiturate1 or carisoprodol2 or 7,c7 a drug with respect to which a risk evaluation and mitigation strategy is required under ,section #eje-a of the ,federal ,food1 ,drug1 and ,cosmetic ,act4 7b7 ,autoimmune or blood disorder drug defined ,in this section1 the term autoimmune or blood disorder drug means a drug or biological product that is indicated and prescribed for the treatment of an autoimmune disease1 hemophilia1 or ,von ,willebrand disease4 4 7#b7 ,clerical amendment ,the table of contents in section #a of the ,employee ,retirement ,income ,security ,act of #aigd 7#bi ,u4,s4,c4 #ajja et seq47 is amended by inserting after the item relating to section #gbf the following3 ,sec4 #gbg4 ,requirements with respect to coverage of drugs for autoimmune diseases and certain blood disorders4 4 7b7 ,public ,health ,service ,act amendments ,part ,d of title ,,xxvii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;gg-#aaa et seq47 is amended by adding at the end the following new section3 #bgii;,a-#ab4 ,requirements with respect to coverage of drugs for autoimmune diseases and certain blood disorders 7a7 ,in general ,a group health plan1 and a health insurance issuer offering group or individual health insurance coverage-- 7#a7 shall provide coverage for any drug that is an autoimmune or blood disorder drug1 without regard to whether such drug is dispensed by a pharmacy or furnished incident to another item or service for which benefits are available under such plan or coverage2 and 7#b7 may not require1 with respect to an individual enrolled under such plan or coverage1 that prior authorization for such a drug be obtained more than once during any #ab-month period unless such drug is-- 7,a7 typically used for a period of #ab months or less2 7,b7 an opioid1 a benzodiazepine1 a barbiturate1 or carisoprodol2 or 7,c7 a drug with respect to which a risk evaluation and mitigation strategy is required under ,section #eje-a of the ,federal ,food1 ,drug1 and ,cosmetic ,act4 7b7 ,autoimmune or blood disorder drug defined ,in this section1 the term autoimmune or blood disorder drug means a drug or biological product that is indicated and prescribed for the treatment of an autoimmune disease1 hemophilia1 or ,von ,willebrand disease4 4 7c7 ,internal ,revenue ,code amendments 7#a7 ,in general ,subchapter ,b of chapter #ajj of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following new section3 #ihbg4 ,requirements with respect to coverage of drugs for autoimmune diseases and certain blood disorders 7a7 ,in general ,a group health plan-- 7#a7 shall provide coverage for any drug that is an autoimmune or blood disorder drug1 without regard to whether such drug is dispensed by a pharmacy or furnished incident to another item or service for which benefits are available under such plan2 and 7#b7 may not require1 with respect to an individual enrolled under such plan1 that prior authorization for such a drug be obtained more than once during any #ab-month period unless such drug is-- 7,a7 typically used for a period of #ab months or less2 7,b7 an opioid1 a benzodiazepine1 a barbiturate1 or carisoprodol2 or 7,c7 a drug with respect to which a risk evaluation and mitigation strategy is required under ,section #eje-a of the ,federal ,food1 ,drug1 and ,cosmetic ,act4 7b7 ,autoimmune or blood disorder drug defined ,in this section1 the term autoimmune or blood disorder drug means a drug or biological product that is indicated and prescribed for the treatment of an autoimmune disease1 hemophilia1 or ,von ,willebrand disease4 4 7#b7 ,clerical amendment ,the table of sections for subchapter ,b of chapter #ajj of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following new item3 ,sec4 #ihbg4 ,requirements with respect to coverage of drugs for autoimmune diseases and certain blood disorders4 4 7d7 ,effective date ,the amendments made by this section shall apply with respect to plan years beginning on or after ,january #a1 #bjbg4